nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—MTHFR—coronary artery disease	0.129	0.75	CbGaD
Methotrexate—ALB—coronary artery disease	0.043	0.25	CbGaD
Methotrexate—PGD—Furosemide—coronary artery disease	0.0257	0.0469	CbGbCtD
Methotrexate—SLC16A1—Niacin—coronary artery disease	0.0225	0.041	CbGbCtD
Methotrexate—SLCO1B3—Olmesartan—coronary artery disease	0.0181	0.033	CbGbCtD
Methotrexate—SLC16A1—Pravastatin—coronary artery disease	0.0174	0.0317	CbGbCtD
Methotrexate—SLCO1B3—Pitavastatin—coronary artery disease	0.0145	0.0264	CbGbCtD
Methotrexate—SLCO1B3—Telmisartan—coronary artery disease	0.0145	0.0264	CbGbCtD
Methotrexate—SLCO1B3—Valsartan—coronary artery disease	0.0141	0.0257	CbGbCtD
Methotrexate—SLC22A7—Enalapril—coronary artery disease	0.0121	0.022	CbGbCtD
Methotrexate—ABCC3—Ezetimibe—coronary artery disease	0.012	0.0219	CbGbCtD
Methotrexate—SLCO1B1—Gemfibrozil—coronary artery disease	0.0111	0.0203	CbGbCtD
Methotrexate—SLCO1B3—Rosuvastatin—coronary artery disease	0.0107	0.0195	CbGbCtD
Methotrexate—SLCO1B1—Olmesartan—coronary artery disease	0.0105	0.0192	CbGbCtD
Methotrexate—SLCO1B3—Pravastatin—coronary artery disease	0.00971	0.0177	CbGbCtD
Methotrexate—ABCC2—Olmesartan—coronary artery disease	0.00927	0.0169	CbGbCtD
Methotrexate—ABCC4—Rosuvastatin—coronary artery disease	0.00918	0.0167	CbGbCtD
Methotrexate—SLC22A7—Acetylsalicylic acid—coronary artery disease	0.00916	0.0167	CbGbCtD
Methotrexate—SLC22A11—Pravastatin—coronary artery disease	0.00897	0.0164	CbGbCtD
Methotrexate—SLCO1B3—Atorvastatin—coronary artery disease	0.00884	0.0161	CbGbCtD
Methotrexate—SLC22A7—Pravastatin—coronary artery disease	0.00855	0.0156	CbGbCtD
Methotrexate—SLCO1A2—Enalapril—coronary artery disease	0.00847	0.0154	CbGbCtD
Methotrexate—SLCO1B1—Pitavastatin—coronary artery disease	0.00843	0.0154	CbGbCtD
Methotrexate—SLCO1B1—Valsartan—coronary artery disease	0.0082	0.015	CbGbCtD
Methotrexate—SLCO1B3—Losartan—coronary artery disease	0.00809	0.0147	CbGbCtD
Methotrexate—SLC22A11—Furosemide—coronary artery disease	0.00763	0.0139	CbGbCtD
Methotrexate—ABCC4—Atorvastatin—coronary artery disease	0.00761	0.0139	CbGbCtD
Methotrexate—ABCC2—Pitavastatin—coronary artery disease	0.00741	0.0135	CbGbCtD
Methotrexate—ABCC2—Telmisartan—coronary artery disease	0.00741	0.0135	CbGbCtD
Methotrexate—ABCC1—Rosuvastatin—coronary artery disease	0.00738	0.0135	CbGbCtD
Methotrexate—SLC22A8—Enalapril—coronary artery disease	0.00738	0.0135	CbGbCtD
Methotrexate—ABCG2—Pitavastatin—coronary artery disease	0.0067	0.0122	CbGbCtD
Methotrexate—ABCG2—Telmisartan—coronary artery disease	0.0067	0.0122	CbGbCtD
Methotrexate—SLCO1A2—Rosuvastatin—coronary artery disease	0.00659	0.012	CbGbCtD
Methotrexate—SLCO1B1—Ezetimibe—coronary artery disease	0.00622	0.0113	CbGbCtD
Methotrexate—SLCO1B1—Rosuvastatin—coronary artery disease	0.00622	0.0113	CbGbCtD
Methotrexate—SLCO1A2—Simvastatin—coronary artery disease	0.00612	0.0112	CbGbCtD
Methotrexate—ABCC1—Atorvastatin—coronary artery disease	0.00611	0.0111	CbGbCtD
Methotrexate—SLCO1A2—Pravastatin—coronary artery disease	0.00599	0.0109	CbGbCtD
Methotrexate—SLCO1A2—Lovastatin—coronary artery disease	0.00599	0.0109	CbGbCtD
Methotrexate—SLCO1B1—Simvastatin—coronary artery disease	0.00578	0.0105	CbGbCtD
Methotrexate—SLCO1B1—Pravastatin—coronary artery disease	0.00565	0.0103	CbGbCtD
Methotrexate—SLCO1B1—Lovastatin—coronary artery disease	0.00565	0.0103	CbGbCtD
Methotrexate—ABCC2—Ezetimibe—coronary artery disease	0.00546	0.00996	CbGbCtD
Methotrexate—SLCO1A2—Atorvastatin—coronary artery disease	0.00546	0.00995	CbGbCtD
Methotrexate—SLC22A8—Pravastatin—coronary artery disease	0.00522	0.00952	CbGbCtD
Methotrexate—SLCO1B1—Atorvastatin—coronary artery disease	0.00515	0.00939	CbGbCtD
Methotrexate—SLC22A6—Enalapril—coronary artery disease	0.00514	0.00937	CbGbCtD
Methotrexate—ABCC2—Simvastatin—coronary artery disease	0.00508	0.00926	CbGbCtD
Methotrexate—ABCC2—Lovastatin—coronary artery disease	0.00497	0.00906	CbGbCtD
Methotrexate—ABCC2—Pravastatin—coronary artery disease	0.00497	0.00906	CbGbCtD
Methotrexate—ABCG2—Ezetimibe—coronary artery disease	0.00494	0.009	CbGbCtD
Methotrexate—ABCG2—Rosuvastatin—coronary artery disease	0.00494	0.009	CbGbCtD
Methotrexate—SLCO1B1—Losartan—coronary artery disease	0.00471	0.00859	CbGbCtD
Methotrexate—ALB—Pitavastatin—coronary artery disease	0.00462	0.00842	CbGbCtD
Methotrexate—ABCC2—Atorvastatin—coronary artery disease	0.00453	0.00825	CbGbCtD
Methotrexate—ABCG2—Pravastatin—coronary artery disease	0.00449	0.00819	CbGbCtD
Methotrexate—ALB—Valsartan—coronary artery disease	0.00449	0.00819	CbGbCtD
Methotrexate—ABCB1—Ticagrelor—coronary artery disease	0.00447	0.00816	CbGbCtD
Methotrexate—SLC22A8—Furosemide—coronary artery disease	0.00444	0.00809	CbGbCtD
Methotrexate—ABCC2—Furosemide—coronary artery disease	0.00422	0.0077	CbGbCtD
Methotrexate—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.00389	0.0071	CbGbCtD
Methotrexate—SLC22A6—Captopril—coronary artery disease	0.00385	0.00701	CbGbCtD
Methotrexate—SLC22A6—Pravastatin—coronary artery disease	0.00364	0.00663	CbGbCtD
Methotrexate—ALB—Rosuvastatin—coronary artery disease	0.0034	0.00621	CbGbCtD
Methotrexate—ALB—Acetylsalicylic acid—coronary artery disease	0.00332	0.00605	CbGbCtD
Methotrexate—ALB—Captopril—coronary artery disease	0.00328	0.00597	CbGbCtD
Methotrexate—SLC22A6—Furosemide—coronary artery disease	0.00309	0.00564	CbGbCtD
Methotrexate—SLC22A6—Losartan—coronary artery disease	0.00303	0.00552	CbGbCtD
Methotrexate—ABCB1—Clopidogrel—coronary artery disease	0.00276	0.00504	CbGbCtD
Methotrexate—ABCB1—Perindopril—coronary artery disease	0.00276	0.00504	CbGbCtD
Methotrexate—ALB—Furosemide—coronary artery disease	0.00263	0.0048	CbGbCtD
Methotrexate—ALB—Losartan—coronary artery disease	0.00258	0.0047	CbGbCtD
Methotrexate—ABCB1—Telmisartan—coronary artery disease	0.00241	0.0044	CbGbCtD
Methotrexate—ABCB1—Pitavastatin—coronary artery disease	0.00241	0.0044	CbGbCtD
Methotrexate—ABCB1—Enalapril—coronary artery disease	0.00229	0.00417	CbGbCtD
Methotrexate—ABCB1—Lisinopril—coronary artery disease	0.00229	0.00417	CbGbCtD
Methotrexate—ABCB1—Timolol—coronary artery disease	0.00195	0.00355	CbGbCtD
Methotrexate—ABCB1—Ezetimibe—coronary artery disease	0.00178	0.00325	CbGbCtD
Methotrexate—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00173	0.00316	CbGbCtD
Methotrexate—ABCB1—Captopril—coronary artery disease	0.00171	0.00313	CbGbCtD
Methotrexate—ABCB1—Simvastatin—coronary artery disease	0.00166	0.00302	CbGbCtD
Methotrexate—ABCB1—Lovastatin—coronary artery disease	0.00162	0.00295	CbGbCtD
Methotrexate—ABCB1—Pravastatin—coronary artery disease	0.00162	0.00295	CbGbCtD
Methotrexate—ABCB1—Atorvastatin—coronary artery disease	0.00148	0.00269	CbGbCtD
Methotrexate—ABCB1—Losartan—coronary artery disease	0.00135	0.00246	CbGbCtD
Methotrexate—MTHFR—artery—coronary artery disease	0.00113	0.0479	CbGeAlD
Methotrexate—FPGS—cardiac ventricle—coronary artery disease	0.000882	0.0373	CbGeAlD
Methotrexate—FPGS—Fluspirilene—Ezetimibe—coronary artery disease	0.000877	0.405	CbGdCrCtD
Methotrexate—SLC19A1—heart—coronary artery disease	0.00087	0.0368	CbGeAlD
Methotrexate—FOLR1—blood—coronary artery disease	0.00074	0.0313	CbGeAlD
Methotrexate—GGH—heart—coronary artery disease	0.000659	0.0279	CbGeAlD
Methotrexate—SLC19A1—blood—coronary artery disease	0.000649	0.0275	CbGeAlD
Methotrexate—SLCO3A1—cardiac ventricle—coronary artery disease	0.000624	0.0264	CbGeAlD
Methotrexate—SLCO3A1—myocardium—coronary artery disease	0.000587	0.0248	CbGeAlD
Methotrexate—FPGS—heart—coronary artery disease	0.000579	0.0245	CbGeAlD
Methotrexate—DHFR—cardiac ventricle—coronary artery disease	0.000573	0.0243	CbGeAlD
Methotrexate—ATIC—heart—coronary artery disease	0.00056	0.0237	CbGeAlD
Methotrexate—DHFR—myocardium—coronary artery disease	0.000539	0.0228	CbGeAlD
Methotrexate—ATIC—cardiovascular system—coronary artery disease	0.000529	0.0224	CbGeAlD
Methotrexate—PGD—myocardium—coronary artery disease	0.000518	0.0219	CbGeAlD
Methotrexate—SLC16A1—cardiac ventricle—coronary artery disease	0.000514	0.0218	CbGeAlD
Methotrexate—FPGS—cardiac atrium—coronary artery disease	0.000496	0.021	CbGeAlD
Methotrexate—GGH—blood—coronary artery disease	0.000492	0.0208	CbGeAlD
Methotrexate—SLC16A1—myocardium—coronary artery disease	0.000484	0.0205	CbGeAlD
Methotrexate—ABCC10—cardiac ventricle—coronary artery disease	0.000472	0.02	CbGeAlD
Methotrexate—SLCO4C1—blood—coronary artery disease	0.000436	0.0185	CbGeAlD
Methotrexate—FPGS—blood—coronary artery disease	0.000432	0.0183	CbGeAlD
Methotrexate—ATIC—blood—coronary artery disease	0.000418	0.0177	CbGeAlD
Methotrexate—MTHFR—heart—coronary artery disease	0.000416	0.0176	CbGeAlD
Methotrexate—SLCO3A1—heart—coronary artery disease	0.00041	0.0173	CbGeAlD
Methotrexate—MTHFR—cardiovascular system—coronary artery disease	0.000393	0.0166	CbGeAlD
Methotrexate—DHFR—heart—coronary artery disease	0.000376	0.0159	CbGeAlD
Methotrexate—PGD—heart—coronary artery disease	0.000362	0.0153	CbGeAlD
Methotrexate—DHFR—cardiovascular system—coronary artery disease	0.000355	0.015	CbGeAlD
Methotrexate—SLCO3A1—cardiac atrium—coronary artery disease	0.00035	0.0148	CbGeAlD
Methotrexate—PGD—cardiovascular system—coronary artery disease	0.000341	0.0144	CbGeAlD
Methotrexate—SLC16A1—heart—coronary artery disease	0.000338	0.0143	CbGeAlD
Methotrexate—DHFR—cardiac atrium—coronary artery disease	0.000322	0.0136	CbGeAlD
Methotrexate—AOX1—heart—coronary artery disease	0.000319	0.0135	CbGeAlD
Methotrexate—SLC16A1—cardiovascular system—coronary artery disease	0.000319	0.0135	CbGeAlD
Methotrexate—ABCC1—myocardium—coronary artery disease	0.000314	0.0133	CbGeAlD
Methotrexate—MTHFR—blood—coronary artery disease	0.000311	0.0132	CbGeAlD
Methotrexate—ABCC10—heart—coronary artery disease	0.00031	0.0131	CbGeAlD
Methotrexate—PGD—cardiac atrium—coronary artery disease	0.000309	0.0131	CbGeAlD
Methotrexate—SLCO3A1—blood—coronary artery disease	0.000306	0.0129	CbGeAlD
Methotrexate—Folic Acid—MTHFR—coronary artery disease	0.000304	0.5	CrCbGaD
Methotrexate—Tetrahydrofolic acid—MTHFR—coronary artery disease	0.000304	0.5	CrCbGaD
Methotrexate—SLC16A1—cardiac atrium—coronary artery disease	0.000289	0.0122	CbGeAlD
Methotrexate—TYMS—blood—coronary artery disease	0.000284	0.012	CbGeAlD
Methotrexate—DHFR—blood—coronary artery disease	0.000281	0.0119	CbGeAlD
Methotrexate—AOX1—cardiac atrium—coronary artery disease	0.000273	0.0115	CbGeAlD
Methotrexate—PGD—blood—coronary artery disease	0.00027	0.0114	CbGeAlD
Methotrexate—ALB—heart—coronary artery disease	0.000266	0.0112	CbGeAlD
Methotrexate—ABCC10—cardiac atrium—coronary artery disease	0.000265	0.0112	CbGeAlD
Methotrexate—ABCC4—heart—coronary artery disease	0.000257	0.0109	CbGeAlD
Methotrexate—SLCO1B1—blood—coronary artery disease	0.000245	0.0104	CbGeAlD
Methotrexate—ABCC3—blood—coronary artery disease	0.000233	0.00984	CbGeAlD
Methotrexate—ABCC10—blood—coronary artery disease	0.000231	0.0098	CbGeAlD
Methotrexate—TYMS—Fluvastatin—Pitavastatin—coronary artery disease	0.000226	0.104	CbGdCrCtD
Methotrexate—ABCC1—heart—coronary artery disease	0.000219	0.00928	CbGeAlD
Methotrexate—TYMS—Fluvastatin—Rosuvastatin—coronary artery disease	0.000201	0.093	CbGdCrCtD
Methotrexate—TYMS—Simvastatin—Pravastatin—coronary artery disease	0.000192	0.0889	CbGdCrCtD
Methotrexate—TYMS—Simvastatin—Lovastatin—coronary artery disease	0.000192	0.0889	CbGdCrCtD
Methotrexate—ABCC4—blood—coronary artery disease	0.000192	0.00813	CbGeAlD
Methotrexate—SLC22A8—blood—coronary artery disease	0.00019	0.00806	CbGeAlD
Methotrexate—ABCC1—cardiac atrium—coronary artery disease	0.000188	0.00794	CbGeAlD
Methotrexate—ABCC2—blood—coronary artery disease	0.000186	0.00787	CbGeAlD
Methotrexate—ABCG2—heart—coronary artery disease	0.000182	0.00769	CbGeAlD
Methotrexate—TYMS—Fluvastatin—Atorvastatin—coronary artery disease	0.000171	0.0791	CbGdCrCtD
Methotrexate—TYMS—Pitavastatin—Rosuvastatin—coronary artery disease	0.000164	0.0758	CbGdCrCtD
Methotrexate—ABCC1—blood—coronary artery disease	0.000164	0.00693	CbGeAlD
Methotrexate—TYMS—Pitavastatin—Atorvastatin—coronary artery disease	0.00014	0.0645	CbGdCrCtD
Methotrexate—ABCG2—blood—coronary artery disease	0.000136	0.00574	CbGeAlD
Methotrexate—ABCB1—heart—coronary artery disease	8.96e-05	0.00379	CbGeAlD
Methotrexate—ABCB1—cardiovascular system—coronary artery disease	8.45e-05	0.00358	CbGeAlD
Methotrexate—ABCB1—blood—coronary artery disease	6.68e-05	0.00283	CbGeAlD
Methotrexate—Myalgia—Timolol—coronary artery disease	3.03e-05	0.000206	CcSEcCtD
Methotrexate—Vomiting—Ezetimibe—coronary artery disease	3.03e-05	0.000206	CcSEcCtD
Methotrexate—Hypersensitivity—Pravastatin—coronary artery disease	3.02e-05	0.000205	CcSEcCtD
Methotrexate—Gastrointestinal pain—Perindopril—coronary artery disease	3.02e-05	0.000205	CcSEcCtD
Methotrexate—Pruritus—Olmesartan—coronary artery disease	3.02e-05	0.000205	CcSEcCtD
Methotrexate—Decreased appetite—Losartan—coronary artery disease	3.01e-05	0.000205	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	3.01e-05	0.000205	CcSEcCtD
Methotrexate—Body temperature increased—Captopril—coronary artery disease	3.01e-05	0.000204	CcSEcCtD
Methotrexate—Abdominal pain—Captopril—coronary artery disease	3.01e-05	0.000204	CcSEcCtD
Methotrexate—Dizziness—Simvastatin—coronary artery disease	3e-05	0.000204	CcSEcCtD
Methotrexate—Rash—Ezetimibe—coronary artery disease	3e-05	0.000204	CcSEcCtD
Methotrexate—Dermatitis—Ezetimibe—coronary artery disease	3e-05	0.000204	CcSEcCtD
Methotrexate—Confusional state—Ramipril—coronary artery disease	3e-05	0.000204	CcSEcCtD
Methotrexate—Discomfort—Timolol—coronary artery disease	3e-05	0.000204	CcSEcCtD
Methotrexate—Asthenia—Niacin—coronary artery disease	2.99e-05	0.000203	CcSEcCtD
Methotrexate—Fatigue—Losartan—coronary artery disease	2.99e-05	0.000203	CcSEcCtD
Methotrexate—Headache—Ezetimibe—coronary artery disease	2.98e-05	0.000203	CcSEcCtD
Methotrexate—Malaise—Lisinopril—coronary artery disease	2.98e-05	0.000202	CcSEcCtD
Methotrexate—Anaphylactic shock—Ramipril—coronary artery disease	2.97e-05	0.000202	CcSEcCtD
Methotrexate—Vertigo—Lisinopril—coronary artery disease	2.97e-05	0.000202	CcSEcCtD
Methotrexate—Pain—Losartan—coronary artery disease	2.97e-05	0.000201	CcSEcCtD
Methotrexate—Vomiting—Eplerenone—coronary artery disease	2.96e-05	0.000201	CcSEcCtD
Methotrexate—Feeling abnormal—Furosemide—coronary artery disease	2.96e-05	0.000201	CcSEcCtD
Methotrexate—Leukopenia—Lisinopril—coronary artery disease	2.96e-05	0.000201	CcSEcCtD
Methotrexate—Nausea—Fenofibrate—coronary artery disease	2.95e-05	0.000201	CcSEcCtD
Methotrexate—Pruritus—Niacin—coronary artery disease	2.95e-05	0.0002	CcSEcCtD
Methotrexate—Asthenia—Pravastatin—coronary artery disease	2.95e-05	0.0002	CcSEcCtD
Methotrexate—Gastrointestinal pain—Furosemide—coronary artery disease	2.94e-05	0.0002	CcSEcCtD
Methotrexate—Rash—Eplerenone—coronary artery disease	2.94e-05	0.0002	CcSEcCtD
Methotrexate—Urticaria—Perindopril—coronary artery disease	2.94e-05	0.0002	CcSEcCtD
Methotrexate—Hypersensitivity—Trandolapril—coronary artery disease	2.94e-05	0.0002	CcSEcCtD
Methotrexate—Dermatitis—Eplerenone—coronary artery disease	2.94e-05	0.000199	CcSEcCtD
Methotrexate—Diarrhoea—Valsartan—coronary artery disease	2.93e-05	0.000199	CcSEcCtD
Methotrexate—Confusional state—Timolol—coronary artery disease	2.93e-05	0.000199	CcSEcCtD
Methotrexate—Hypersensitivity—Enalapril—coronary artery disease	2.93e-05	0.000199	CcSEcCtD
Methotrexate—Body temperature increased—Perindopril—coronary artery disease	2.92e-05	0.000199	CcSEcCtD
Methotrexate—Abdominal pain—Perindopril—coronary artery disease	2.92e-05	0.000199	CcSEcCtD
Methotrexate—Diarrhoea—Olmesartan—coronary artery disease	2.92e-05	0.000198	CcSEcCtD
Methotrexate—Headache—Eplerenone—coronary artery disease	2.92e-05	0.000198	CcSEcCtD
Methotrexate—Nervous system disorder—Ramipril—coronary artery disease	2.92e-05	0.000198	CcSEcCtD
Methotrexate—Thrombocytopenia—Ramipril—coronary artery disease	2.91e-05	0.000198	CcSEcCtD
Methotrexate—Anaphylactic shock—Timolol—coronary artery disease	2.91e-05	0.000197	CcSEcCtD
Methotrexate—Pruritus—Pravastatin—coronary artery disease	2.9e-05	0.000197	CcSEcCtD
Methotrexate—Nausea—Clopidogrel—coronary artery disease	2.9e-05	0.000197	CcSEcCtD
Methotrexate—Skin disorder—Ramipril—coronary artery disease	2.89e-05	0.000196	CcSEcCtD
Methotrexate—Infection—Timolol—coronary artery disease	2.89e-05	0.000196	CcSEcCtD
Methotrexate—Vomiting—Simvastatin—coronary artery disease	2.89e-05	0.000196	CcSEcCtD
Methotrexate—Hypersensitivity—Telmisartan—coronary artery disease	2.89e-05	0.000196	CcSEcCtD
Methotrexate—Cough—Lisinopril—coronary artery disease	2.88e-05	0.000196	CcSEcCtD
Methotrexate—Nausea—Lovastatin—coronary artery disease	2.88e-05	0.000196	CcSEcCtD
Methotrexate—Hyperhidrosis—Ramipril—coronary artery disease	2.87e-05	0.000195	CcSEcCtD
Methotrexate—Rash—Simvastatin—coronary artery disease	2.86e-05	0.000194	CcSEcCtD
Methotrexate—Dermatitis—Simvastatin—coronary artery disease	2.86e-05	0.000194	CcSEcCtD
Methotrexate—Asthenia—Trandolapril—coronary artery disease	2.86e-05	0.000194	CcSEcCtD
Methotrexate—Feeling abnormal—Losartan—coronary artery disease	2.86e-05	0.000194	CcSEcCtD
Methotrexate—Urticaria—Furosemide—coronary artery disease	2.86e-05	0.000194	CcSEcCtD
Methotrexate—Diarrhoea—Niacin—coronary artery disease	2.85e-05	0.000194	CcSEcCtD
Methotrexate—Nervous system disorder—Timolol—coronary artery disease	2.85e-05	0.000194	CcSEcCtD
Methotrexate—Asthenia—Enalapril—coronary artery disease	2.85e-05	0.000194	CcSEcCtD
Methotrexate—Headache—Simvastatin—coronary artery disease	2.84e-05	0.000193	CcSEcCtD
Methotrexate—Abdominal pain—Furosemide—coronary artery disease	2.84e-05	0.000193	CcSEcCtD
Methotrexate—Body temperature increased—Furosemide—coronary artery disease	2.84e-05	0.000193	CcSEcCtD
Methotrexate—Gastrointestinal pain—Losartan—coronary artery disease	2.84e-05	0.000193	CcSEcCtD
Methotrexate—Dizziness—Valsartan—coronary artery disease	2.84e-05	0.000193	CcSEcCtD
Methotrexate—Anorexia—Ramipril—coronary artery disease	2.83e-05	0.000193	CcSEcCtD
Methotrexate—Nausea—Ezetimibe—coronary artery disease	2.83e-05	0.000192	CcSEcCtD
Methotrexate—Skin disorder—Timolol—coronary artery disease	2.82e-05	0.000192	CcSEcCtD
Methotrexate—Dizziness—Olmesartan—coronary artery disease	2.82e-05	0.000192	CcSEcCtD
Methotrexate—Pruritus—Trandolapril—coronary artery disease	2.82e-05	0.000192	CcSEcCtD
Methotrexate—Myalgia—Lisinopril—coronary artery disease	2.81e-05	0.000191	CcSEcCtD
Methotrexate—Arthralgia—Lisinopril—coronary artery disease	2.81e-05	0.000191	CcSEcCtD
Methotrexate—Chest pain—Lisinopril—coronary artery disease	2.81e-05	0.000191	CcSEcCtD
Methotrexate—Hyperhidrosis—Timolol—coronary artery disease	2.81e-05	0.000191	CcSEcCtD
Methotrexate—Asthenia—Telmisartan—coronary artery disease	2.81e-05	0.000191	CcSEcCtD
Methotrexate—Pruritus—Enalapril—coronary artery disease	2.81e-05	0.000191	CcSEcCtD
Methotrexate—Diarrhoea—Pravastatin—coronary artery disease	2.81e-05	0.000191	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.79e-05	0.00019	CcSEcCtD
Methotrexate—Discomfort—Lisinopril—coronary artery disease	2.78e-05	0.000189	CcSEcCtD
Methotrexate—Hypotension—Ramipril—coronary artery disease	2.78e-05	0.000189	CcSEcCtD
Methotrexate—Anorexia—Timolol—coronary artery disease	2.77e-05	0.000188	CcSEcCtD
Methotrexate—Pruritus—Telmisartan—coronary artery disease	2.77e-05	0.000188	CcSEcCtD
Methotrexate—Nausea—Eplerenone—coronary artery disease	2.77e-05	0.000188	CcSEcCtD
Methotrexate—Dizziness—Niacin—coronary artery disease	2.76e-05	0.000187	CcSEcCtD
Methotrexate—Urticaria—Losartan—coronary artery disease	2.75e-05	0.000187	CcSEcCtD
Methotrexate—Body temperature increased—Losartan—coronary artery disease	2.74e-05	0.000186	CcSEcCtD
Methotrexate—Abdominal pain—Losartan—coronary artery disease	2.74e-05	0.000186	CcSEcCtD
Methotrexate—Asthenia—Captopril—coronary artery disease	2.73e-05	0.000186	CcSEcCtD
Methotrexate—Diarrhoea—Trandolapril—coronary artery disease	2.73e-05	0.000185	CcSEcCtD
Methotrexate—Vomiting—Valsartan—coronary artery disease	2.73e-05	0.000185	CcSEcCtD
Methotrexate—Confusional state—Lisinopril—coronary artery disease	2.72e-05	0.000185	CcSEcCtD
Methotrexate—Diarrhoea—Enalapril—coronary artery disease	2.72e-05	0.000185	CcSEcCtD
Methotrexate—Hypotension—Timolol—coronary artery disease	2.72e-05	0.000185	CcSEcCtD
Methotrexate—Dizziness—Pravastatin—coronary artery disease	2.71e-05	0.000184	CcSEcCtD
Methotrexate—Vomiting—Olmesartan—coronary artery disease	2.71e-05	0.000184	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.71e-05	0.000184	CcSEcCtD
Methotrexate—Rash—Valsartan—coronary artery disease	2.7e-05	0.000184	CcSEcCtD
Methotrexate—Dermatitis—Valsartan—coronary artery disease	2.7e-05	0.000183	CcSEcCtD
Methotrexate—Nausea—Simvastatin—coronary artery disease	2.7e-05	0.000183	CcSEcCtD
Methotrexate—Anaphylactic shock—Lisinopril—coronary artery disease	2.7e-05	0.000183	CcSEcCtD
Methotrexate—Pruritus—Captopril—coronary artery disease	2.69e-05	0.000183	CcSEcCtD
Methotrexate—Rash—Olmesartan—coronary artery disease	2.69e-05	0.000183	CcSEcCtD
Methotrexate—Insomnia—Ramipril—coronary artery disease	2.69e-05	0.000183	CcSEcCtD
Methotrexate—Dermatitis—Olmesartan—coronary artery disease	2.69e-05	0.000183	CcSEcCtD
Methotrexate—Headache—Valsartan—coronary artery disease	2.69e-05	0.000182	CcSEcCtD
Methotrexate—Diarrhoea—Telmisartan—coronary artery disease	2.68e-05	0.000182	CcSEcCtD
Methotrexate—Infection—Lisinopril—coronary artery disease	2.68e-05	0.000182	CcSEcCtD
Methotrexate—Headache—Olmesartan—coronary artery disease	2.67e-05	0.000182	CcSEcCtD
Methotrexate—Paraesthesia—Ramipril—coronary artery disease	2.67e-05	0.000181	CcSEcCtD
Methotrexate—Asthenia—Perindopril—coronary artery disease	2.65e-05	0.00018	CcSEcCtD
Methotrexate—Dyspnoea—Ramipril—coronary artery disease	2.65e-05	0.00018	CcSEcCtD
Methotrexate—Vomiting—Niacin—coronary artery disease	2.65e-05	0.00018	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Timolol—coronary artery disease	2.65e-05	0.00018	CcSEcCtD
Methotrexate—Hypersensitivity—Furosemide—coronary artery disease	2.65e-05	0.00018	CcSEcCtD
Methotrexate—Somnolence—Ramipril—coronary artery disease	2.64e-05	0.00018	CcSEcCtD
Methotrexate—Thrombocytopenia—Lisinopril—coronary artery disease	2.64e-05	0.000179	CcSEcCtD
Methotrexate—Dizziness—Trandolapril—coronary artery disease	2.64e-05	0.000179	CcSEcCtD
Methotrexate—Insomnia—Timolol—coronary artery disease	2.63e-05	0.000179	CcSEcCtD
Methotrexate—Rash—Niacin—coronary artery disease	2.63e-05	0.000179	CcSEcCtD
Methotrexate—Dermatitis—Niacin—coronary artery disease	2.63e-05	0.000178	CcSEcCtD
Methotrexate—Dizziness—Enalapril—coronary artery disease	2.63e-05	0.000178	CcSEcCtD
Methotrexate—Skin disorder—Lisinopril—coronary artery disease	2.62e-05	0.000178	CcSEcCtD
Methotrexate—Dyspepsia—Ramipril—coronary artery disease	2.62e-05	0.000178	CcSEcCtD
Methotrexate—Pruritus—Perindopril—coronary artery disease	2.62e-05	0.000178	CcSEcCtD
Methotrexate—Headache—Niacin—coronary artery disease	2.61e-05	0.000177	CcSEcCtD
Methotrexate—Paraesthesia—Timolol—coronary artery disease	2.61e-05	0.000177	CcSEcCtD
Methotrexate—Vomiting—Pravastatin—coronary artery disease	2.61e-05	0.000177	CcSEcCtD
Methotrexate—Hyperhidrosis—Lisinopril—coronary artery disease	2.61e-05	0.000177	CcSEcCtD
Methotrexate—Diarrhoea—Captopril—coronary artery disease	2.61e-05	0.000177	CcSEcCtD
Methotrexate—Dyspnoea—Timolol—coronary artery disease	2.59e-05	0.000176	CcSEcCtD
Methotrexate—Dizziness—Telmisartan—coronary artery disease	2.59e-05	0.000176	CcSEcCtD
Methotrexate—Rash—Pravastatin—coronary artery disease	2.59e-05	0.000176	CcSEcCtD
Methotrexate—Dermatitis—Pravastatin—coronary artery disease	2.59e-05	0.000176	CcSEcCtD
Methotrexate—Decreased appetite—Ramipril—coronary artery disease	2.58e-05	0.000176	CcSEcCtD
Methotrexate—Somnolence—Timolol—coronary artery disease	2.58e-05	0.000176	CcSEcCtD
Methotrexate—Asthenia—Furosemide—coronary artery disease	2.58e-05	0.000175	CcSEcCtD
Methotrexate—Headache—Pravastatin—coronary artery disease	2.57e-05	0.000175	CcSEcCtD
Methotrexate—Anorexia—Lisinopril—coronary artery disease	2.57e-05	0.000175	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Ramipril—coronary artery disease	2.57e-05	0.000174	CcSEcCtD
Methotrexate—Fatigue—Ramipril—coronary artery disease	2.56e-05	0.000174	CcSEcCtD
Methotrexate—Dyspepsia—Timolol—coronary artery disease	2.56e-05	0.000174	CcSEcCtD
Methotrexate—Hypersensitivity—Losartan—coronary artery disease	2.55e-05	0.000174	CcSEcCtD
Methotrexate—Nausea—Valsartan—coronary artery disease	2.55e-05	0.000173	CcSEcCtD
Methotrexate—Pruritus—Furosemide—coronary artery disease	2.54e-05	0.000173	CcSEcCtD
Methotrexate—Nausea—Olmesartan—coronary artery disease	2.53e-05	0.000172	CcSEcCtD
Methotrexate—Vomiting—Trandolapril—coronary artery disease	2.53e-05	0.000172	CcSEcCtD
Methotrexate—Diarrhoea—Perindopril—coronary artery disease	2.53e-05	0.000172	CcSEcCtD
Methotrexate—Decreased appetite—Timolol—coronary artery disease	2.53e-05	0.000172	CcSEcCtD
Methotrexate—Vomiting—Enalapril—coronary artery disease	2.52e-05	0.000171	CcSEcCtD
Methotrexate—Hypotension—Lisinopril—coronary artery disease	2.52e-05	0.000171	CcSEcCtD
Methotrexate—Dizziness—Captopril—coronary artery disease	2.52e-05	0.000171	CcSEcCtD
Methotrexate—Rash—Trandolapril—coronary artery disease	2.51e-05	0.000171	CcSEcCtD
Methotrexate—Dermatitis—Trandolapril—coronary artery disease	2.51e-05	0.000171	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Timolol—coronary artery disease	2.51e-05	0.00017	CcSEcCtD
Methotrexate—Fatigue—Timolol—coronary artery disease	2.51e-05	0.00017	CcSEcCtD
Methotrexate—Rash—Enalapril—coronary artery disease	2.5e-05	0.00017	CcSEcCtD
Methotrexate—Dermatitis—Enalapril—coronary artery disease	2.5e-05	0.00017	CcSEcCtD
Methotrexate—Headache—Trandolapril—coronary artery disease	2.5e-05	0.00017	CcSEcCtD
Methotrexate—Vomiting—Telmisartan—coronary artery disease	2.49e-05	0.000169	CcSEcCtD
Methotrexate—Asthenia—Losartan—coronary artery disease	2.49e-05	0.000169	CcSEcCtD
Methotrexate—Headache—Enalapril—coronary artery disease	2.49e-05	0.000169	CcSEcCtD
Methotrexate—Pain—Timolol—coronary artery disease	2.49e-05	0.000169	CcSEcCtD
Methotrexate—Nausea—Niacin—coronary artery disease	2.48e-05	0.000168	CcSEcCtD
Methotrexate—Rash—Telmisartan—coronary artery disease	2.47e-05	0.000168	CcSEcCtD
Methotrexate—Dermatitis—Telmisartan—coronary artery disease	2.47e-05	0.000168	CcSEcCtD
Methotrexate—Diarrhoea—Furosemide—coronary artery disease	2.46e-05	0.000167	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.46e-05	0.000167	CcSEcCtD
Methotrexate—Pruritus—Losartan—coronary artery disease	2.45e-05	0.000167	CcSEcCtD
Methotrexate—Headache—Telmisartan—coronary artery disease	2.45e-05	0.000167	CcSEcCtD
Methotrexate—Feeling abnormal—Ramipril—coronary artery disease	2.45e-05	0.000166	CcSEcCtD
Methotrexate—Dizziness—Perindopril—coronary artery disease	2.44e-05	0.000166	CcSEcCtD
Methotrexate—Insomnia—Lisinopril—coronary artery disease	2.44e-05	0.000166	CcSEcCtD
Methotrexate—Nausea—Pravastatin—coronary artery disease	2.44e-05	0.000166	CcSEcCtD
Methotrexate—Gastrointestinal pain—Ramipril—coronary artery disease	2.43e-05	0.000165	CcSEcCtD
Methotrexate—Paraesthesia—Lisinopril—coronary artery disease	2.42e-05	0.000165	CcSEcCtD
Methotrexate—Vomiting—Captopril—coronary artery disease	2.42e-05	0.000164	CcSEcCtD
Methotrexate—Dyspnoea—Lisinopril—coronary artery disease	2.4e-05	0.000163	CcSEcCtD
Methotrexate—Rash—Captopril—coronary artery disease	2.4e-05	0.000163	CcSEcCtD
Methotrexate—Dermatitis—Captopril—coronary artery disease	2.4e-05	0.000163	CcSEcCtD
Methotrexate—Somnolence—Lisinopril—coronary artery disease	2.4e-05	0.000163	CcSEcCtD
Methotrexate—Feeling abnormal—Timolol—coronary artery disease	2.4e-05	0.000163	CcSEcCtD
Methotrexate—Headache—Captopril—coronary artery disease	2.39e-05	0.000162	CcSEcCtD
Methotrexate—Gastrointestinal pain—Timolol—coronary artery disease	2.38e-05	0.000161	CcSEcCtD
Methotrexate—Dizziness—Furosemide—coronary artery disease	2.38e-05	0.000161	CcSEcCtD
Methotrexate—Dyspepsia—Lisinopril—coronary artery disease	2.37e-05	0.000161	CcSEcCtD
Methotrexate—Diarrhoea—Losartan—coronary artery disease	2.37e-05	0.000161	CcSEcCtD
Methotrexate—Nausea—Trandolapril—coronary artery disease	2.37e-05	0.000161	CcSEcCtD
Methotrexate—Urticaria—Ramipril—coronary artery disease	2.36e-05	0.00016	CcSEcCtD
Methotrexate—Nausea—Enalapril—coronary artery disease	2.36e-05	0.00016	CcSEcCtD
Methotrexate—Vomiting—Perindopril—coronary artery disease	2.35e-05	0.00016	CcSEcCtD
Methotrexate—Body temperature increased—Ramipril—coronary artery disease	2.35e-05	0.00016	CcSEcCtD
Methotrexate—Abdominal pain—Ramipril—coronary artery disease	2.35e-05	0.00016	CcSEcCtD
Methotrexate—Decreased appetite—Lisinopril—coronary artery disease	2.34e-05	0.000159	CcSEcCtD
Methotrexate—Rash—Perindopril—coronary artery disease	2.33e-05	0.000158	CcSEcCtD
Methotrexate—Dermatitis—Perindopril—coronary artery disease	2.33e-05	0.000158	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.33e-05	0.000158	CcSEcCtD
Methotrexate—Nausea—Telmisartan—coronary artery disease	2.33e-05	0.000158	CcSEcCtD
Methotrexate—Fatigue—Lisinopril—coronary artery disease	2.32e-05	0.000158	CcSEcCtD
Methotrexate—Headache—Perindopril—coronary artery disease	2.32e-05	0.000157	CcSEcCtD
Methotrexate—Urticaria—Timolol—coronary artery disease	2.31e-05	0.000157	CcSEcCtD
Methotrexate—Pain—Lisinopril—coronary artery disease	2.31e-05	0.000157	CcSEcCtD
Methotrexate—Body temperature increased—Timolol—coronary artery disease	2.3e-05	0.000156	CcSEcCtD
Methotrexate—Abdominal pain—Timolol—coronary artery disease	2.3e-05	0.000156	CcSEcCtD
Methotrexate—Dizziness—Losartan—coronary artery disease	2.29e-05	0.000156	CcSEcCtD
Methotrexate—Vomiting—Furosemide—coronary artery disease	2.29e-05	0.000155	CcSEcCtD
Methotrexate—Rash—Furosemide—coronary artery disease	2.27e-05	0.000154	CcSEcCtD
Methotrexate—Dermatitis—Furosemide—coronary artery disease	2.26e-05	0.000154	CcSEcCtD
Methotrexate—Nausea—Captopril—coronary artery disease	2.26e-05	0.000154	CcSEcCtD
Methotrexate—Headache—Furosemide—coronary artery disease	2.25e-05	0.000153	CcSEcCtD
Methotrexate—Feeling abnormal—Lisinopril—coronary artery disease	2.22e-05	0.000151	CcSEcCtD
Methotrexate—Gastrointestinal pain—Lisinopril—coronary artery disease	2.21e-05	0.00015	CcSEcCtD
Methotrexate—Vomiting—Losartan—coronary artery disease	2.2e-05	0.00015	CcSEcCtD
Methotrexate—Nausea—Perindopril—coronary artery disease	2.2e-05	0.000149	CcSEcCtD
Methotrexate—Hypersensitivity—Ramipril—coronary artery disease	2.19e-05	0.000149	CcSEcCtD
Methotrexate—Rash—Losartan—coronary artery disease	2.19e-05	0.000149	CcSEcCtD
Methotrexate—Dermatitis—Losartan—coronary artery disease	2.18e-05	0.000148	CcSEcCtD
Methotrexate—Headache—Losartan—coronary artery disease	2.17e-05	0.000148	CcSEcCtD
Methotrexate—Urticaria—Lisinopril—coronary artery disease	2.14e-05	0.000146	CcSEcCtD
Methotrexate—Hypersensitivity—Timolol—coronary artery disease	2.14e-05	0.000145	CcSEcCtD
Methotrexate—Nausea—Furosemide—coronary artery disease	2.13e-05	0.000145	CcSEcCtD
Methotrexate—Asthenia—Ramipril—coronary artery disease	2.13e-05	0.000145	CcSEcCtD
Methotrexate—Abdominal pain—Lisinopril—coronary artery disease	2.13e-05	0.000145	CcSEcCtD
Methotrexate—Body temperature increased—Lisinopril—coronary artery disease	2.13e-05	0.000145	CcSEcCtD
Methotrexate—Pruritus—Ramipril—coronary artery disease	2.1e-05	0.000143	CcSEcCtD
Methotrexate—Asthenia—Timolol—coronary artery disease	2.09e-05	0.000142	CcSEcCtD
Methotrexate—Nausea—Losartan—coronary artery disease	2.06e-05	0.00014	CcSEcCtD
Methotrexate—Pruritus—Timolol—coronary artery disease	2.06e-05	0.00014	CcSEcCtD
Methotrexate—Diarrhoea—Ramipril—coronary artery disease	2.03e-05	0.000138	CcSEcCtD
Methotrexate—Diarrhoea—Timolol—coronary artery disease	1.99e-05	0.000135	CcSEcCtD
Methotrexate—Hypersensitivity—Lisinopril—coronary artery disease	1.99e-05	0.000135	CcSEcCtD
Methotrexate—Dizziness—Ramipril—coronary artery disease	1.97e-05	0.000134	CcSEcCtD
Methotrexate—Asthenia—Lisinopril—coronary artery disease	1.93e-05	0.000131	CcSEcCtD
Methotrexate—Dizziness—Timolol—coronary artery disease	1.92e-05	0.000131	CcSEcCtD
Methotrexate—Pruritus—Lisinopril—coronary artery disease	1.91e-05	0.00013	CcSEcCtD
Methotrexate—Vomiting—Ramipril—coronary artery disease	1.89e-05	0.000128	CcSEcCtD
Methotrexate—Rash—Ramipril—coronary artery disease	1.87e-05	0.000127	CcSEcCtD
Methotrexate—Dermatitis—Ramipril—coronary artery disease	1.87e-05	0.000127	CcSEcCtD
Methotrexate—Headache—Ramipril—coronary artery disease	1.86e-05	0.000127	CcSEcCtD
Methotrexate—Vomiting—Timolol—coronary artery disease	1.85e-05	0.000126	CcSEcCtD
Methotrexate—Diarrhoea—Lisinopril—coronary artery disease	1.85e-05	0.000125	CcSEcCtD
Methotrexate—Rash—Timolol—coronary artery disease	1.83e-05	0.000125	CcSEcCtD
Methotrexate—Dermatitis—Timolol—coronary artery disease	1.83e-05	0.000124	CcSEcCtD
Methotrexate—Headache—Timolol—coronary artery disease	1.82e-05	0.000124	CcSEcCtD
Methotrexate—Dizziness—Lisinopril—coronary artery disease	1.78e-05	0.000121	CcSEcCtD
Methotrexate—Nausea—Ramipril—coronary artery disease	1.77e-05	0.00012	CcSEcCtD
Methotrexate—Nausea—Timolol—coronary artery disease	1.73e-05	0.000117	CcSEcCtD
Methotrexate—Vomiting—Lisinopril—coronary artery disease	1.71e-05	0.000116	CcSEcCtD
Methotrexate—Rash—Lisinopril—coronary artery disease	1.7e-05	0.000116	CcSEcCtD
Methotrexate—Dermatitis—Lisinopril—coronary artery disease	1.7e-05	0.000115	CcSEcCtD
Methotrexate—Headache—Lisinopril—coronary artery disease	1.69e-05	0.000115	CcSEcCtD
Methotrexate—Nausea—Lisinopril—coronary artery disease	1.6e-05	0.000109	CcSEcCtD
Methotrexate—DHFR—Metabolism—PTGS2—coronary artery disease	1.79e-06	1.68e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.79e-06	1.68e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—coronary artery disease	1.79e-06	1.68e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—NOS3—coronary artery disease	1.79e-06	1.68e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.79e-06	1.68e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HADHA—coronary artery disease	1.77e-06	1.67e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOE—coronary artery disease	1.77e-06	1.66e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MTHFR—coronary artery disease	1.77e-06	1.66e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—LPL—coronary artery disease	1.77e-06	1.66e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOB—coronary artery disease	1.76e-06	1.65e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTA1—coronary artery disease	1.75e-06	1.65e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	1.75e-06	1.65e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—APOA1—coronary artery disease	1.75e-06	1.64e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—coronary artery disease	1.74e-06	1.64e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LPA—coronary artery disease	1.73e-06	1.63e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GPX1—coronary artery disease	1.72e-06	1.62e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTP1—coronary artery disease	1.72e-06	1.62e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—VCAN—coronary artery disease	1.72e-06	1.62e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—NOS3—coronary artery disease	1.71e-06	1.61e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GSTM1—coronary artery disease	1.71e-06	1.61e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MAPK1—coronary artery disease	1.71e-06	1.61e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ALDOA—coronary artery disease	1.71e-06	1.6e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARGC1A—coronary artery disease	1.71e-06	1.6e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—coronary artery disease	1.7e-06	1.6e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—HMOX1—coronary artery disease	1.7e-06	1.6e-05	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.7e-06	1.59e-05	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—AKT1—coronary artery disease	1.68e-06	1.58e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AGT—coronary artery disease	1.68e-06	1.58e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PLCB3—coronary artery disease	1.68e-06	1.58e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—LPL—coronary artery disease	1.68e-06	1.58e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CD36—coronary artery disease	1.68e-06	1.58e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CAT—coronary artery disease	1.68e-06	1.58e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—MAPK1—coronary artery disease	1.67e-06	1.57e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOA5—coronary artery disease	1.66e-06	1.56e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6ST—coronary artery disease	1.66e-06	1.56e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DCN—coronary artery disease	1.66e-06	1.56e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPP2CA—coronary artery disease	1.66e-06	1.56e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS2—coronary artery disease	1.65e-06	1.55e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARG—coronary artery disease	1.65e-06	1.55e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOE—coronary artery disease	1.65e-06	1.55e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—coronary artery disease	1.64e-06	1.54e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—IGF1—coronary artery disease	1.64e-06	1.54e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GPX1—coronary artery disease	1.64e-06	1.54e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—coronary artery disease	1.63e-06	1.53e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—P4HB—coronary artery disease	1.63e-06	1.53e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOB—coronary artery disease	1.63e-06	1.53e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—APOA1—coronary artery disease	1.63e-06	1.53e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—POMC—coronary artery disease	1.62e-06	1.53e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—PIK3CA—coronary artery disease	1.62e-06	1.52e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ALDH2—coronary artery disease	1.61e-06	1.52e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PLA2G1B—coronary artery disease	1.6e-06	1.5e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	1.6e-06	1.5e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—KIT—coronary artery disease	1.6e-06	1.5e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CD36—coronary artery disease	1.6e-06	1.5e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MTHFR—coronary artery disease	1.59e-06	1.49e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GSTM1—coronary artery disease	1.58e-06	1.49e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPP2CA—coronary artery disease	1.58e-06	1.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.57e-06	1.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LIPC—coronary artery disease	1.57e-06	1.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HBA1—coronary artery disease	1.57e-06	1.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2C19—coronary artery disease	1.57e-06	1.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3C2A—coronary artery disease	1.57e-06	1.48e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—coronary artery disease	1.57e-06	1.47e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—coronary artery disease	1.56e-06	1.47e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOC3—coronary artery disease	1.56e-06	1.47e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.56e-06	1.46e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SERPINE1—coronary artery disease	1.56e-06	1.46e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—LPL—coronary artery disease	1.56e-06	1.46e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LDLR—coronary artery disease	1.55e-06	1.46e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.55e-06	1.46e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—coronary artery disease	1.55e-06	1.45e-05	CbGpPWpGaD
Methotrexate—PGD—Metabolism—AKT1—coronary artery disease	1.54e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTT1—coronary artery disease	1.53e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC9A1—coronary artery disease	1.53e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—GSK3B—coronary artery disease	1.53e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—CREB1—coronary artery disease	1.52e-06	1.43e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—MAPK1—coronary artery disease	1.52e-06	1.43e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GPX1—coronary artery disease	1.52e-06	1.43e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCLC—coronary artery disease	1.52e-06	1.42e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CETP—coronary artery disease	1.52e-06	1.42e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTHFR—coronary artery disease	1.51e-06	1.42e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AGT—coronary artery disease	1.51e-06	1.42e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—AKT1—coronary artery disease	1.51e-06	1.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—VCAN—coronary artery disease	1.51e-06	1.42e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SDC1—coronary artery disease	1.5e-06	1.41e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALDOA—coronary artery disease	1.5e-06	1.41e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	1.49e-06	1.4e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—coronary artery disease	1.49e-06	1.4e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PIK3CA—coronary artery disease	1.48e-06	1.39e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6R—coronary artery disease	1.48e-06	1.39e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOE—coronary artery disease	1.48e-06	1.39e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—coronary artery disease	1.48e-06	1.39e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CD36—coronary artery disease	1.48e-06	1.39e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOA1—coronary artery disease	1.46e-06	1.38e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPP2CA—coronary artery disease	1.46e-06	1.37e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DCN—coronary artery disease	1.45e-06	1.37e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—PIK3CA—coronary artery disease	1.45e-06	1.36e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—JAK2—coronary artery disease	1.44e-06	1.36e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AGT—coronary artery disease	1.44e-06	1.35e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—coronary artery disease	1.44e-06	1.35e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARG—coronary artery disease	1.43e-06	1.35e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PSMA6—coronary artery disease	1.42e-06	1.33e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PSMB5—coronary artery disease	1.42e-06	1.33e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—coronary artery disease	1.42e-06	1.33e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—POMC—coronary artery disease	1.41e-06	1.33e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALDH2—coronary artery disease	1.41e-06	1.33e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOE—coronary artery disease	1.41e-06	1.32e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.4e-06	1.32e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTHFR—coronary artery disease	1.4e-06	1.32e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOA1—coronary artery disease	1.39e-06	1.31e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SERPINE1—coronary artery disease	1.39e-06	1.3e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CTGF—coronary artery disease	1.38e-06	1.3e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LIPC—coronary artery disease	1.38e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HBA1—coronary artery disease	1.38e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2C19—coronary artery disease	1.38e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3C2A—coronary artery disease	1.38e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT2—coronary artery disease	1.37e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HMGCR—coronary artery disease	1.37e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOC3—coronary artery disease	1.37e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LDLR—coronary artery disease	1.36e-06	1.28e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC9A1—coronary artery disease	1.34e-06	1.26e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTT1—coronary artery disease	1.34e-06	1.26e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGF2—coronary artery disease	1.34e-06	1.26e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.33e-06	1.25e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AGT—coronary artery disease	1.33e-06	1.25e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCLC—coronary artery disease	1.33e-06	1.25e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CETP—coronary artery disease	1.33e-06	1.25e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	1.33e-06	1.24e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—coronary artery disease	1.33e-06	1.24e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—PIK3CA—coronary artery disease	1.32e-06	1.24e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SDC1—coronary artery disease	1.31e-06	1.23e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—coronary artery disease	1.31e-06	1.23e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	1.31e-06	1.23e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOE—coronary artery disease	1.3e-06	1.22e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—coronary artery disease	1.3e-06	1.22e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARG—coronary artery disease	1.29e-06	1.21e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—coronary artery disease	1.29e-06	1.21e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOA1—coronary artery disease	1.29e-06	1.21e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—JAK2—coronary artery disease	1.29e-06	1.21e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—coronary artery disease	1.28e-06	1.2e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—POMC—coronary artery disease	1.27e-06	1.2e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PLCB1—coronary artery disease	1.26e-06	1.19e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PIK3CA—coronary artery disease	1.24e-06	1.17e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PSMA6—coronary artery disease	1.24e-06	1.17e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PSMB5—coronary artery disease	1.24e-06	1.17e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.24e-06	1.16e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—coronary artery disease	1.23e-06	1.16e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARG—coronary artery disease	1.23e-06	1.15e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ABCA1—coronary artery disease	1.22e-06	1.15e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CTGF—coronary artery disease	1.21e-06	1.14e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PIK3CA—coronary artery disease	1.21e-06	1.14e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—coronary artery disease	1.21e-06	1.14e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—AKT1—coronary artery disease	1.21e-06	1.14e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—POMC—coronary artery disease	1.21e-06	1.14e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HMGCR—coronary artery disease	1.2e-06	1.13e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT2—coronary artery disease	1.2e-06	1.13e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT1—coronary artery disease	1.18e-06	1.11e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GGT1—coronary artery disease	1.18e-06	1.11e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—AKT1—coronary artery disease	1.18e-06	1.11e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.18e-06	1.11e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—coronary artery disease	1.17e-06	1.1e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—coronary artery disease	1.16e-06	1.09e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARG—coronary artery disease	1.14e-06	1.07e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—coronary artery disease	1.13e-06	1.06e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—POMC—coronary artery disease	1.12e-06	1.05e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—coronary artery disease	1.11e-06	1.04e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PLCB1—coronary artery disease	1.11e-06	1.04e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PIK3CA—coronary artery disease	1.1e-06	1.04e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—coronary artery disease	1.1e-06	1.04e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—AKT1—coronary artery disease	1.08e-06	1.01e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ABCA1—coronary artery disease	1.07e-06	1.01e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—VEGFA—coronary artery disease	1.07e-06	1.01e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTP1—coronary artery disease	1.06e-06	9.99e-06	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—coronary artery disease	1.05e-06	9.91e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARGC1A—coronary artery disease	1.05e-06	9.9e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HMOX1—coronary artery disease	1.05e-06	9.85e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GGT1—coronary artery disease	1.04e-06	9.75e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT1—coronary artery disease	1.04e-06	9.75e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CAT—coronary artery disease	1.04e-06	9.72e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—coronary artery disease	1.02e-06	9.59e-06	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—coronary artery disease	1.02e-06	9.53e-06	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—AKT1—coronary artery disease	1.01e-06	9.53e-06	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PIK3CA—coronary artery disease	1e-06	9.44e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOB—coronary artery disease	1e-06	9.44e-06	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—AKT1—coronary artery disease	9.91e-07	9.31e-06	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—coronary artery disease	9.83e-07	9.23e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GSTM1—coronary artery disease	9.78e-07	9.18e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—coronary artery disease	9.77e-07	9.17e-06	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—coronary artery disease	9.65e-07	9.06e-06	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—MAPK1—coronary artery disease	9.64e-07	9.05e-06	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PIK3CA—coronary artery disease	9.63e-07	9.04e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LPL—coronary artery disease	9.6e-07	9.01e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GPX1—coronary artery disease	9.36e-07	8.79e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTP1—coronary artery disease	9.32e-07	8.76e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARGC1A—coronary artery disease	9.23e-07	8.67e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HMOX1—coronary artery disease	9.19e-07	8.63e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CD36—coronary artery disease	9.12e-07	8.56e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CAT—coronary artery disease	9.07e-07	8.52e-06	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—AKT1—coronary artery disease	9.01e-07	8.47e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPP2CA—coronary artery disease	9e-07	8.46e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—coronary artery disease	8.93e-07	8.39e-06	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PIK3CA—coronary artery disease	8.83e-07	8.3e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOB—coronary artery disease	8.81e-07	8.27e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—coronary artery disease	8.76e-07	8.23e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTHFR—coronary artery disease	8.64e-07	8.12e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MAPK1—coronary artery disease	8.59e-07	8.07e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GSTM1—coronary artery disease	8.57e-07	8.05e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LPL—coronary artery disease	8.41e-07	7.9e-06	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PIK3CA—coronary artery disease	8.36e-07	7.86e-06	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—AKT1—coronary artery disease	8.21e-07	7.71e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AGT—coronary artery disease	8.21e-07	7.71e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GPX1—coronary artery disease	8.2e-07	7.7e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOE—coronary artery disease	8.04e-07	7.56e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CD36—coronary artery disease	7.99e-07	7.5e-06	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PIK3CA—coronary artery disease	7.97e-07	7.49e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOA1—coronary artery disease	7.95e-07	7.47e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPP2CA—coronary artery disease	7.89e-07	7.41e-06	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—AKT1—coronary artery disease	7.87e-07	7.39e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.61e-07	7.15e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTHFR—coronary artery disease	7.57e-07	7.11e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PIK3CA—coronary artery disease	7.46e-07	7e-06	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—AKT1—coronary artery disease	7.22e-07	6.78e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AGT—coronary artery disease	7.19e-07	6.76e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOE—coronary artery disease	7.05e-07	6.62e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARG—coronary artery disease	7.01e-07	6.58e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOA1—coronary artery disease	6.97e-07	6.54e-06	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PIK3CA—coronary artery disease	6.94e-07	6.52e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—POMC—coronary artery disease	6.91e-07	6.49e-06	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—AKT1—coronary artery disease	6.83e-07	6.42e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—coronary artery disease	6.6e-07	6.2e-06	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—AKT1—coronary artery disease	6.51e-07	6.12e-06	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PIK3CA—coronary artery disease	6.24e-07	5.87e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARG—coronary artery disease	6.14e-07	5.77e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—AKT1—coronary artery disease	6.09e-07	5.72e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—POMC—coronary artery disease	6.05e-07	5.69e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—coronary artery disease	6.03e-07	5.66e-06	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	5.93e-07	5.57e-06	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AKT1—coronary artery disease	5.67e-07	5.33e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—coronary artery disease	5.52e-07	5.18e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—coronary artery disease	5.51e-07	5.18e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PIK3CA—coronary artery disease	5.49e-07	5.16e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—coronary artery disease	5.28e-07	4.96e-06	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AKT1—coronary artery disease	5.1e-07	4.79e-06	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AKT1—coronary artery disease	4.85e-07	4.55e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—coronary artery disease	4.83e-07	4.54e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AKT1—coronary artery disease	4.49e-07	4.22e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3CA—coronary artery disease	3.39e-07	3.18e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3CA—coronary artery disease	2.97e-07	2.79e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AKT1—coronary artery disease	2.77e-07	2.6e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AKT1—coronary artery disease	2.43e-07	2.28e-06	CbGpPWpGaD
